Login / Signup

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States.

Tetsuya TajimaOlivia M MartinezDaniel BernsteinScott D BoydDita A GratzingerGrant LumKazunari SasakiBrent TanClare J TwistKenneth WeinbergBrian ArmstrongDev M DesaiGeorge Vincent MazariegosClifford ChinThomas M FishbeinAkin TekinRobert S VenickSheri M KramsCarlos O Esquivel
Published in: Pediatric transplantation (2024)
D+R- is a risk factor for PTLD and EBV DNAemia and associated with the incidence of monomorphic/polymorphic PTLD. Intensive follow-up of EBV viral load within 6-month post-transplant, especially for patients with D+R- and/or non-liver transplant recipients ≥5 years of age at transplant, may help detect monomorphic/polymorphic PTLD early in pediatric transplant.
Keyphrases
  • epstein barr virus
  • diffuse large b cell lymphoma
  • risk factors
  • stem cells
  • cell therapy
  • bone marrow
  • childhood cancer